Target intelligence / Profile preview

CD300 antigen pseudogene

Molecular classification
Pseudogene
01

Overview

CD300 antigen pseudogene (ENSG00000236770) is a non-functional genomic locus derived from the CD300 family, which encompasses immunoglobulin superfamily receptors that modulate immune cell activity through inhibitory and activating signals[1][5]. Unlike its functional relatives (such as CD300A and CD300C), a pseudogene is defined by mutations that prevent its transcription or translation, and it does not encode a protein with canonical receptor activity or therapeutic relevance[3][5]. Thus, it lacks the biological roles, drug interactions, and molecular classification characteristic of true receptor targets. If you need information on the functional CD300 family receptors (e.g., CD300A or CD300C), these are cell-surface immune regulators but do not share these properties with pseudogenes like ENSG00000236770[1][5].

Beyond the preview

Go deeper on CD300 antigen pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CD300 antigen pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call